Garuda Therapeutics develops an off‑the‑shelf platform to produce self‑renewing, HLA‑compatible, transgene‑free blood stem cells and HSC‑derived immune cells for scalable transplantation and oncology applications.
garudatx.comPart of: Boston tech scene from Fundable